Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients - News-Medical.Net

Researchers evaluated the immune responses after the third and fourth doses of homologous and heterologous mRNA vaccines against COVID-19 in kidney transplant recipients.

In a recent study posted to the medRxiv* preprint server, researchers evaluated the immune responses after the third (V3) and fourth (V4) doses of homologous and heterologous messenger ribonucleic ac… [+5274 chars]

full article...